Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Last Updated: 11/03/15

William C. Timmer, PhD

William C.  Timmer, PhD

Program Director

Dr. William Timmer joined CGCB as a Program Director (Health Science Administrator) in September 2007. His principal effort is directed toward management of a portfolio of clinical oncology research grants (principally involving brain, head and neck, lung, liver, colorectal, pancreatic and sarcoma cancers) within CTEP. He is also the NCI Program Director for the Adult Brain Tumor Consortium.

Dr. Timmer received his PhD in Chemistry from the University of Wisconsin, and he immediately began his federal career at the NIH. He studied the immunoregulatory effects of cytokines on HIV replication in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases. He subsequently joined the Food and Drug Administration where, over a fifteen year period, he held a variety of scientific and regulatory positions of increasing influence in three different FDA Centers: Foods, Drugs, and Biologics. At the Centers for Drugs and Biologics, Dr. Timmer evaluated regulatory submissions in the areas of HIV detection kits, cellular and gene therapies, medical devices and several currently-marketed oncology drugs.

Dr. Timmer has over 50 publications and presentations to his credit. He has received numerous honor awards from both the NIH and the FDA, and has recently completed twenty-seven years of federal service.

About the Branch Chief

Roy Wu, PhD Following graduation from the University of California at Berkeley and the Albert Einstein College of Medicine, Dr. Wu was a post-doctoral fellow and Lecturer in the Department of Zoology at the University of California at Berkeley. Prior to joining the federal government in 1979, he worked for a biotech company as a Senior Scientist for 5 years. In 1986 after working for 7 years in the Laboratory of Molecular Pharmacology of the NCI's intramural program, More…